Recently, it has been shown that deregulation in propionate metabolism contributes to an anaplerotic reaction in the accumulation of methylmalonic acid (MMA) mediated by ERK2 signaling resulting in breast and lung cancer with an increased EMT and metastatic potential (Gomes et al, 2022). The gene discussed is MAPK1; the disease is lung cancer.